We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
(+2.2%)
Cap. Flow
-$488M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$101M |
| 2 |
GE Vernova
GEV
|
+$75.4M |
| 3 |
CRH
CRH
|
+$48.5M |
| 4 |
CrowdStrike
CRWD
|
+$45.8M |
| 5 |
Dell
DELL
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$180M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$121M |
| 3 |
GE Aerospace
GE
|
+$59.1M |
| 4 |
UnitedHealth
UNH
|
+$46.6M |
| 5 |
NVIDIA
NVDA
|
+$38.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.98% |
| 2 | Financials | 12.55% |
| 3 | Healthcare | 11.48% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Legend Biotech
LEGN
$4.01B
| $1.17M | ﹤0.01% |
26,334
+2,704
| +11% | +$125K |
|
2127
United States Lime & Minerals
USLM
$3.44B
| $1.16M | ﹤0.01% |
15,960
+355
| +2% | +$23.6K |
|
2128
Cadre Holdings
CDRE
$1.41B
| $1.16M | ﹤0.01% |
34,568
+8,502
| +33% | +$280K |
|
2129
Enliven Therapeutics
ELVN
$4.43B
| $1.16M | ﹤0.01% |
49,627
+11,420
| +30% | +$240K |
|
|
DESP
2130
DELISTED
Despegar.com
DESP
| $1.16M | ﹤0.01% |
+87,628
| New | +$1.15M |
|
2131
ORIX
IX
$43.5B
| $1.16M | ﹤0.01% |
52,035
-1,950
| -4% | -$41.6K |
|
2132
Compass Minerals
CMP
$1.15B
| $1.16M | ﹤0.01% |
112,035
+7,966
| +8% | +$103K |
|
2133
Central Garden & Pet Co
CENT
$2.8B
| $1.16M | ﹤0.01% |
30,058
+157
| +0.5% | +$6.56K |
|
2134
Perella Weinberg Partners
PWP
$1.3B
| $1.15M | ﹤0.01% |
70,867
+14,978
| +27% | +$226K |
|
|
LBPH
2135
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.15M | ﹤0.01% |
42,476
+12,500
| +42% | +$247K |
|
2136
Globalstar
GSAT
$10.8B
| $1.14M | ﹤0.01% |
68,122
+1,899
| +3% | +$34.2K |
|
2137
Amer Sports
AS
$21.4B
| $1.14M | ﹤0.01% |
+90,815
| New | +$1.33M |
|
2138
Merchants Bancorp
MBIN
$2.49B
| $1.14M | ﹤0.01% |
28,124
+2,971
| +12% | +$122K |
|
2139
Center Bancorp
CNOB
$1.78B
| $1.14M | ﹤0.01% |
60,337
+22
| +0% | +$413 |
|
2140
Smith & Wesson
SWBI
$637M
| $1.14M | ﹤0.01% |
79,360
+655
| +0.8% | +$10.8K |
|
|
UDMY
2141
DELISTED
Udemy
UDMY
| $1.14M | ﹤0.01% |
131,847
+11,699
| +10% | +$111K |
|
2142
Claros Mortgage Trust
CMTG
$274M
| $1.14M | ﹤0.01% |
141,808
-8,262
| -6% | -$70.1K |
|
2143
Lennar Class B
LEN.B
$20.8B
| $1.14M | ﹤0.01% |
8,571
-1,787
| -17% | -$245K |
|
2144
Birkenstock
BIRK
$7.07B
| $1.13M | ﹤0.01% |
20,694
-141
| -0.7% | -$6.99K |
|
2145
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $1.13M | ﹤0.01% |
112,172
+4,149
| +4% | +$44.5K |
|
2146
Royal Bank of Canada
RY
$293B
| $1.12M | ﹤0.01% |
10,495
-1,613
| -13% | -$166K |
|
2147
Gorman-Rupp
GRC
$2.21B
| $1.11M | ﹤0.01% |
30,345
-4,049
| -12% | -$143K |
|
2148
Cass Information Systems
CASS
$743M
| $1.11M | ﹤0.01% |
27,753
-1,104
| -4% | -$48.1K |
|
2149
National Presto Industries
NPK
$989M
| $1.11M | ﹤0.01% |
14,784
+593
| +4% | +$46.7K |
|
2150
PureCycle Technologies
PCT
$1.45B
| $1.11M | ﹤0.01% |
186,984
+9,769
| +6% | +$53.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2024 Portfolio in Review
As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
- RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
- RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
- RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
- RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
- RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.
Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.